ArticleHuman cell2026
DKK1 exacerbates dental pulp inflammation: insights from RNA-sequencing analysis.
Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Dickkopf-related protein 1 (DKK1) has been implicated in several inflammatory diseases; however, its role in pulpitis remains poorly understood. This study aimed to investigate the role and underlying molecular mechanisms of DKK1 on pulpitis using inflamed dental pulp cells (DPCs) as the experimental model. RNA-sequencing (RNA-seq) was conducted on varying concentrations of lipopolysaccharide (LPS)-treated DPCs. Subsequent bioinformatic analyses revealed distinct transcriptional expression patterns between moderate inflammation induced by 1 μg/ml LPS and excessive inflammation induced by 10 μg/ml LPS. Furthermore, the addition of recombinant DKK1 (200 ng/ml) to DPCs treated with 1 μg/ml LPS further enhanced the production of pro-inflammatory cytokines. Bioinformatic analyses based on RNA-seq data identified 24 hub genes in DKK1-stimulated inflamed DPCs, among which the interleukin-17 (IL-17) signaling pathway was the most significantly enriched. Correspondingly, recombinant DKK1 increased the expression of IL-17 receptor in inflamed DPCs. Taken together, these findings indicate that under moderate inflammatory conditions, DKK1 exacerbates inflammation in DPCs through enhancing the production of pro-inflammatory mediators, potentially via modulation of the IL-17 signaling pathway. Thus, targeting DKK1 might have therapeutic potential for promoting the resolution of moderate pulpitis and preventing its severe progression.
Indexed as
Identifiers
41758406What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.